USPTO serial 85293918
SARMONT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 15, 2011
- Examiner
- SAITO, KIM
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with SARMONT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
St. Louis, MO
St. Louis, MO
St. Louis, MO
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Matthew J. Smith
MATTHEW J. SMITH POLSINELLI SHUGHART PC100 S 4TH ST STE 1000SAINT LOUIS, MO 63102-1825UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Contract scientific and technical research for pharmaceuticals, biotech products and chemicals; pharmaceutical drug discovery, development and research in the fields of pharmaceuticals, biotech products, chemicals; clinical trials for drugs; consumer testing services for ensuring the safety and efficacy of drugs; research services in the areas of chemistry, pharmacology, medicinal chemistry, organic and inorganic chemistry, synthetic chemistry, analogue chemistry, and computational chemistry; Scientific research and development services, namely, laboratory research and monitoring of clinical trials for diagnostic tests for drug screening, instruments for drug screening, and pharmaceuticals; Scientific and technological services for drug development and discovery; Scientific and technological services to identify novel drug targets and research and design relating thereto, and scientific and technological services to characterize off-target activities of candidate and established drugs to understand the basis for their efficacy and toxicity and research and design relating thereto; Chemical and pharmaceutical research and development for others; laboratory research in the field of analytical and medicinal chemistry | SECTION 8 - CANCELLED | Jan 1, 2011 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 22, 2018 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Nov 15, 2016 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Nov 15, 2011 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 30, 2011 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 30, 2011 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 22, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 19, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 19, 2011 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 16, 2011 | NWAP | NEW APPLICATION ENTERED | — |